Christopher S. Walker

3.5k total citations
57 papers, 2.1k citations indexed

About

Christopher S. Walker is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Christopher S. Walker has authored 57 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 26 papers in Psychiatry and Mental health. Recurrent topics in Christopher S. Walker's work include Neuropeptides and Animal Physiology (43 papers), Migraine and Headache Studies (25 papers) and Receptor Mechanisms and Signaling (20 papers). Christopher S. Walker is often cited by papers focused on Neuropeptides and Animal Physiology (43 papers), Migraine and Headache Studies (25 papers) and Receptor Mechanisms and Signaling (20 papers). Christopher S. Walker collaborates with scholars based in New Zealand, United Kingdom and United States. Christopher S. Walker's co-authors include Debbie L. Hay, David R. Poyner, Michael L. Garelja, Rebekah L. Bower, Andrew F. Russo, Erica R. Hendrikse, Tayla A. Rees, Paul W. R. Harris, Alex C. Conner and Andrew Siow and has published in prestigious journals such as Molecular Cell, Neurology and Annals of Neurology.

In The Last Decade

Christopher S. Walker

54 papers receiving 2.0k citations

Peers

Countries citing papers authored by Christopher S. Walker

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Walker more than expected).

Fields of papers citing papers by Christopher S. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Walker. The network helps show where Christopher S. Walker may publish in the future.

Co-authorship network of co-authors of Christopher S. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Walker. A scholar is included among the top collaborators of Christopher S. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Walker. Christopher S. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354 2024 ·Frontiers in Pharmacology ·Tayla A. Rees, (unknown), (unknown), Sung‐Hyun Yang, Paul W. R. Harris, Christopher S. Walker	2
2	Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5‐HT_1A Signalling 2024 ·ChemMedChem ·(unknown), Tayla A. Rees, (unknown), Christopher S. Walker, Lisa I. Pilkington, David Barker	0
3	Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC₁ receptor 2024 ·British Journal of Pharmacology ·(unknown), Tayla A. Rees, Song Guo, (unknown), Simon J. O’Carroll, Richard L. M. Faull, Maurice A. Curtis, Sarah Louise Christensen, Debbie L. Hay, Christopher S. Walker	6
4	Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia 2024 ·The Journal of Headache and Pain ·Tayla A. Rees, (unknown), Michael L. Garelja, Simon J. O’Carroll, Christopher S. Walker, Debbie L. Hay	10
5	PAC1, VPAC1, and VPAC2 Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies 2022 ·International Journal of Molecular Sciences ·(unknown), Andrew Siow, Paul W. R. Harris, Margaret A. Brimble, Simon J. O’Carroll, Debbie L. Hay, Christopher S. Walker	10
6	Calcitonin receptor antibody validation and expression in the rodent brain 2022 ·Cephalalgia ·Erica R. Hendrikse, Tayla A. Rees, (unknown), Christelle Le Foll, Thomas A. Lutz, Andrew Siow, Peter J. Wookey, Christopher S. Walker, Debbie L. Hay	12
7	Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor Pharmacology 2022 ·ACS Pharmacology & Translational Science ·(unknown), (unknown), Andrew Siow, Tayla A. Rees, Margaret A. Brimble, Paul W. R. Harris, Debbie L. Hay, Christopher S. Walker	5
8	Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale 2022 ·International Journal of Molecular Sciences ·Erica R. Hendrikse, Tayla A. Rees, (unknown), Michael L. Garelja, Andrew Siow, Paul W. R. Harris, John B. Pawlak, Kathleen M. Caron, (unknown), Andrew F. Russo, Levi P. Sowers, Thomas A. Lutz, Christelle Le Foll, Christopher S. Walker, Debbie L. Hay	8
9	CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons 2022 ·Frontiers in Physiology ·Tayla A. Rees, Andrew F. Russo, Simon J. O’Carroll, Debbie L. Hay, Christopher S. Walker	20
10	Decrease in Body Weight With Once-Daily Atogepant for the Preventive Treatment of Migraine: A Post Hoc Analysis (P1-2.002) 2022 ·Neurology ·David W. Dodick, Debbie L. Hay, Christopher S. Walker, Peter J. Goadsby, Jessica Ailani, Lawrence Severt, Michelle Finnegan, (unknown), Hua Guo, Joel M. Trugman	1
11	Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine 2021 ·Neurology ·Hashmat Ghanizada, Mohammad Al‐Mahdi Al‐Karagholi, Nanna Arngrim, (unknown), Christopher S. Walker, Debbie L. Hay, Messoud Ashina	40
12	Characterisation of agonist signalling profiles and agonist‐dependent antagonism at PACAP‐responsive receptors: Implications for drug discovery 2021 ·British Journal of Pharmacology ·(unknown), Andrew Siow, Paul W. R. Harris, Margaret A. Brimble, Debbie L. Hay, Christopher S. Walker	28
13	Antagonism of CGRP Signaling by Rimegepant at Two Receptors 2020 ·Frontiers in Pharmacology ·(unknown), Andrew Siow, Debbie L. Hay, Christopher S. Walker	43
14	Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin 2018 ·ACS Pharmacology & Translational Science ·Rebekah L. Bower, (unknown), Tayla A. Rees, Giuseppe Deganutti, Erica R. Hendrikse, Paul W. R. Harris, Renata Kowalczyk, Zachary Ridgway, Amy G. Wong, (unknown), Daniel P. Raleigh, Augen A. Pioszak, Margaret A. Brimble, Christopher A. Reynolds, Christopher S. Walker, Debbie L. Hay	65
15	Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25 2017 ·British Journal of Pharmacology ·Debbie L. Hay, Michael L. Garelja, David R. Poyner, Christopher S. Walker	286
16	Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs 2017 ·Biochemical Pharmacology ·Michael J. Woolley, Christopher A. Reynolds, John Simms, Christopher S. Walker, Juan Carlos Mobarec, Michael L. Garelja, Alex C. Conner, David R. Poyner, Debbie L. Hay	29
17	Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor 2015 ·Molecular Cell ·(unknown), Christopher S. Walker, James Barwell, Gabriel Kuteyi, John Simms, Aqfan Jamaluddin, Margaret L. Warner, Roslyn M. Bill, Paul W. R. Harris, Margaret A. Brimble, David R. Poyner, Debbie L. Hay, Augen A. Pioszak	99
18	CGRPin the trigeminovascular system: a role forCGRP, adrenomedullin and amylin receptors? 2013 ·British Journal of Pharmacology ·Christopher S. Walker, Debbie L. Hay	76
19	Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes 2011 ·British Journal of Pharmacology ·(unknown), Christopher S. Walker, (unknown), (unknown), (unknown), (unknown), Lynda Whiting, (unknown), Debbie L. Hay	85
20	Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges 2010 ·Endocrine Related Cancer ·Debbie L. Hay, Christopher S. Walker, David R. Poyner	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact